Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-20

Clinical Trial Update: A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base [NA]

View source ↗

Summary

A pilot clinical trial evaluating double curettage and cautery followed by topical imiquimod for facial basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod (Aldara) (Imiquimod)

Snippet

Sponsor: University of Glasgow | Conditions: Basal Cell Carcinoma | NA | Status: UNKNOWN